Greenlight Capital Inc

Q1 2015 13F Holdings Report, New Holdings, Stock Holdings

Signature - Title
Daniel Roitman - Chief Operating Officer
Location
New York
Holdings as of
March 31, 2015
Value $
$134M
Num holdings
1
Date filed
7/23/2015, 04:25 PM
Form type
13F-HR/A-1 - New Holdings
Description
Top holdings included UIL. Request for Confidential Treatment (5/15/2015): Confidential Treatment Expired on 7/15/2015.
Previous filing
Q4 2014 - Feb 13, 2015
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 05-15-2015 pursuant to a request for confidential treatment and for which confidential treatment expired on 07-15-2015.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Daniel Roitman Chief Operating Officer New York, New York 7/17/2015

Other Included Managers (3):

Num Name Location File Number
1 DME Advisors, LP New York, NY 028-13228
2 DME Capital Management, LP New York, NY 028-14000
3 Greenlight Masters, LLC New York, NY 028-13259